1. Home
  2. BYFC vs SERA Comparison

BYFC vs SERA Comparison

Compare BYFC & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

N/A

Current Price

$7.60

Market Cap

71.7M

Sector

Finance

ML Signal

N/A

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$1.99

Market Cap

77.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYFC
SERA
Founded
1946
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
77.2M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
BYFC
SERA
Price
$7.60
$1.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.6K
93.6K
Earning Date
07-31-2025
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.32
EPS
N/A
N/A
Revenue
$155,000.00
$81,000.00
Revenue This Year
N/A
$875.93
Revenue Next Year
N/A
$248.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.19
52 Week Low
$5.51
$1.37
52 Week High
$8.85
$4.09

Technical Indicators

Market Signals
Indicator
BYFC
SERA
Relative Strength Index (RSI) 42.29 42.61
Support Level $7.19 $1.80
Resistance Level $7.85 $2.00
Average True Range (ATR) 0.06 0.21
MACD -0.02 0.03
Stochastic Oscillator 21.43 41.98

Price Performance

Historical Comparison
BYFC
SERA

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: